Australia Seeks Views On Plans To Drop Dual Drug Substance Names
Executive Summary
Dozens of pharmaceutical ingredients have two different names in Australia, which can be a source of confusion. The country’s regulator is planning to require such substances to have a single name from next April, although this could be deferred for certain ingredients if stakeholders feel it is warranted.
You may also be interested in...
Australia Sets Timelines For Phasing Out Dual Substance Names
Companies marketing medicines containing certain dual-named substances will have until 30 April 2026 to move to sole names, while other products can retain their dual names either for a transition period or in perpetuity.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.